Bypassing Agents for Bleeding Prophylaxis in Hemophilia B: A Clinical Conundrum?

Am J Ther. 2018 Nov/Dec;25(6):e770-e771. doi: 10.1097/MJT.0000000000000776.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Blood Coagulation / physiology
  • Factor VIII / therapeutic use*
  • Hematoma, Subdural, Chronic / prevention & control
  • Hemophilia B / complications
  • Hemophilia B / drug therapy*
  • Hemophilia B / immunology*
  • Humans
  • Male

Substances

  • Factor VIII